American Trust cut its holdings in Integral Ad Science Holding Corp. (NASDAQ:IAS – Free Report) by 9.5% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 12,045 shares of the company’s stock after selling 1,260 shares during the quarter. American Trust’s holdings in Integral Ad Science were worth $130,000 at the end of the most recent reporting period.
A number of other institutional investors have also made changes to their positions in the business. Franklin Resources Inc. increased its holdings in shares of Integral Ad Science by 12.9% in the third quarter. Franklin Resources Inc. now owns 110,449 shares of the company’s stock valued at $1,191,000 after purchasing an additional 12,647 shares in the last quarter. Barclays PLC raised its position in shares of Integral Ad Science by 207.1% during the third quarter. Barclays PLC now owns 127,733 shares of the company’s stock worth $1,380,000 after acquiring an additional 86,133 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Integral Ad Science by 6.4% during the third quarter. Geode Capital Management LLC now owns 1,834,659 shares of the company’s stock valued at $19,836,000 after acquiring an additional 110,149 shares during the period. Public Employees Retirement System of Ohio bought a new position in Integral Ad Science in the third quarter valued at about $138,000. Finally, Washington Harbour Partners LP acquired a new stake in Integral Ad Science in the third quarter worth about $1,744,000. 95.78% of the stock is owned by institutional investors.
Integral Ad Science Stock Down 0.4 %
Shares of Integral Ad Science stock opened at $10.58 on Friday. The company has a market capitalization of $1.72 billion, a P/E ratio of 52.90, a price-to-earnings-growth ratio of 1.49 and a beta of 1.45. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71. The business has a 50-day moving average of $11.14 and a two-hundred day moving average of $10.66. Integral Ad Science Holding Corp. has a 1 year low of $7.98 and a 1 year high of $17.53.
Insider Buying and Selling
In other news, CEO Lisa Utzschneider sold 10,481 shares of the firm’s stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total transaction of $105,962.91. Following the completion of the transaction, the chief executive officer now directly owns 239,709 shares of the company’s stock, valued at $2,423,457.99. This trade represents a 4.19 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Tania Secor sold 5,240 shares of the business’s stock in a transaction on Monday, October 7th. The stock was sold at an average price of $10.11, for a total transaction of $52,976.40. Following the completion of the sale, the chief financial officer now directly owns 248,223 shares in the company, valued at approximately $2,509,534.53. This represents a 2.07 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 16,363 shares of company stock worth $165,629 over the last ninety days. Company insiders own 2.00% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on IAS. Scotiabank initiated coverage on shares of Integral Ad Science in a research report on Thursday, December 5th. They set a “sector perform” rating and a $10.00 target price on the stock. Truist Financial reduced their price objective on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Oppenheimer dropped their target price on shares of Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating for the company in a research report on Wednesday, November 13th. Benchmark restated a “hold” rating on shares of Integral Ad Science in a research report on Thursday, November 14th. Finally, Piper Sandler dropped their price objective on Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating for the company in a report on Wednesday, November 13th. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $15.18.
Get Our Latest Report on Integral Ad Science
Integral Ad Science Company Profile
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
See Also
- Five stocks we like better than Integral Ad Science
- What Investors Need to Know to Beat the Market
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is an Earnings Surprise?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- How to Evaluate a Stock Before BuyingÂ
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding IAS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integral Ad Science Holding Corp. (NASDAQ:IAS – Free Report).
Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.